Total raised
—
Stage
Mature
Founded
2002
Headcount
1-10
HQ
Ashdod
Sector
Health Tech & Life Sciences
About
Aferrix develops tools for the early diagnosis and monitoring of serum iron toxicity. The companys solutions include methods that quantify different forms of toxic iron not detected by conventional tests. Aferrix offers iron testing services and kits for research and treatment centers specializing in iron overload diseases (e.g. thalassemia, hemochromatosis, and myelodysplastic syndrome) and for pharmaceutical companies that are developing iron chelators. All of the companys products are CE marked for IVD use.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Aferrix's primary focus?
- Aferrix develops tools for the early diagnosis and monitoring of serum iron toxicity, specifically quantifying forms of toxic iron not detected by conventional tests.
- When was Aferrix founded?
- Aferrix was founded in February 2002.
- What is the current operational status of Aferrix?
- Aferrix is currently inactive, having ceased operations in January 2023.
- Where is Aferrix headquartered?
- Aferrix is headquartered in Ashdod, South District, Israel.
- What types of customers does Aferrix target?
- Aferrix targets healthcare and life sciences organizations, including laboratories, providers, and pharmaceutical and biotechnology companies.
- What is the primary product offered by Aferrix?
- Aferrix offers a product named FeROS, which is a diagnostic tool.
- In which geographic market does Aferrix have a presence?
- Aferrix has a presence in the geographic market of India.
- Are Aferrix's products certified for medical use?
- Yes, all of Aferrix's products are CE marked for IVD (In Vitro Diagnostic) use.
- Who is a founder of Aferrix?
- Ioav Cabantchik is a founder of Aferrix.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesProvidersLife SciencesPharmaceuticalsBiotechnology
Business model
B2B
Highlights
1 Patents
Tags
diagnosticspharma-companiesblood-testmeasurementsmedical-technologieslaboratoriesmonitoringdetection